Clinical trial
Randomised Double-blinded Trial Comparing Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis Relapses
NCT00984984 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Double-blinded Trial Comparing Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis Relapses
- Lead sponsor
- Rennes University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2008
- Completion date
- June 30, 2014
- Enrollment
- 200 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.